126 related articles for article (PubMed ID: 8370766)
1. Neurovascular permeability and fibrin deposition in the central neuraxis of Lewis rats with cell-transferred experimental allergic encephalomyelitis in relationship to clinical and histopathological features of the disease.
Koh CS; Gausas J; Paterson PY
J Neuroimmunol; 1993 Sep; 47(2):141-5. PubMed ID: 8370766
[TBL] [Abstract][Full Text] [Related]
2. Concordance and localization of maximal vascular permeability change and fibrin deposition in the central neuraxis of Lewis rats with cell-transferred experimental allergic encephalomyelitis.
Koh CS; Gausas J; Paterson PY
J Neuroimmunol; 1992 May; 38(1-2):85-93. PubMed ID: 1577954
[TBL] [Abstract][Full Text] [Related]
3. Experimental allergic encephalomyelitis: role of fibrin deposition in immunopathogenesis of inflammation in rats.
Paterson PY
Fed Proc; 1976 Nov; 35(13):2428-34. PubMed ID: 61895
[TBL] [Abstract][Full Text] [Related]
4. Suppression of cell-transferred experimental autoimmune encephalomyelitis in defibrinated Lewis rats.
Inoue A; Koh CS; Shimada K; Yanagisawa N; Yoshimura K
J Neuroimmunol; 1996 Dec; 71(1-2):131-7. PubMed ID: 8982112
[TBL] [Abstract][Full Text] [Related]
5. Suppression of clinical signs of cell-transferred experimental allergic encephalomyelitis and altered cerebrovascular permeability in Lewis rats treated with a plasminogen activator inhibitor.
Koh CS; Paterson PY
Cell Immunol; 1987 Jun; 107(1):52-63. PubMed ID: 2438054
[TBL] [Abstract][Full Text] [Related]
6. Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat.
Juhler M; Barry DI; Offner H; Konat G; Klinken L; Paulson OB
Brain Res; 1984 Jun; 302(2):347-55. PubMed ID: 6610460
[TBL] [Abstract][Full Text] [Related]
7. Neurovascular fibrinolytic activity in normal Lewis rats and rats with cell-transferred experimental allergic encephalomyelitis.
Koh CS; Kwaan HC; Paterson PY
J Neuroimmunol; 1990 Aug; 28(3):189-200. PubMed ID: 2373760
[TBL] [Abstract][Full Text] [Related]
8. The immunopathology of adoptively transferred experimental allergic encephalomyelitis (EAE) in Lewis rats. Part 1. Immunohistochemical examination of developing lesions of EAE.
Matsumoto Y; Fujiwara M
J Neurol Sci; 1987 Jan; 77(1):35-47. PubMed ID: 2433404
[TBL] [Abstract][Full Text] [Related]
9. Demyelination and early remyelination in experimental allergic encephalomyelitis passively transferred with myelin basic protein-sensitized lymphocytes in the Lewis rat.
Pender MP; Nguyen KB; Willenborg DO
J Neuroimmunol; 1989 Dec; 25(2-3):125-42. PubMed ID: 2479658
[TBL] [Abstract][Full Text] [Related]
10. Early detection of liposome brain localization in rat experimental allergic encephalomyelitis.
Rousseau V; Denizot B; Le Jeune JJ; Jallet P
Exp Brain Res; 1999 Apr; 125(3):255-64. PubMed ID: 10229016
[TBL] [Abstract][Full Text] [Related]
11. A spatial analysis of the blood-brain barrier damage in experimental allergic encephalomyelitis.
Juhler M; Blasberg RG; Fenstermacher JD; Patlak CS; Paulson OB
J Cereb Blood Flow Metab; 1985 Dec; 5(4):545-53. PubMed ID: 3877064
[TBL] [Abstract][Full Text] [Related]
12. Role of the clotting system in the pathogenesis of neuroimmunologic disease.
Paterson PY; Koh CS; Kwaan HC
Fed Proc; 1987 Jan; 46(1):91-6. PubMed ID: 2433164
[TBL] [Abstract][Full Text] [Related]
13. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
Meeson AP; Piddlesden S; Morgan BP; Reynolds R
Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
[TBL] [Abstract][Full Text] [Related]
14. Modulation of blood-brain barrier dysfunction and neurological deficits during acute experimental allergic encephalomyelitis by the N-methyl-D-aspartate receptor antagonist memantine.
Paul C; Bolton C
J Pharmacol Exp Ther; 2002 Jul; 302(1):50-7. PubMed ID: 12065699
[TBL] [Abstract][Full Text] [Related]
15. Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in the spinal cord of rats during acute experimental allergic encephalomyelitis.
Matsuda M; Tsukada N; Koh CS; Iwahashi T; Shimada K; Yanagisawa N
Autoimmunity; 1994; 19(1):15-22. PubMed ID: 7749038
[TBL] [Abstract][Full Text] [Related]
16. Relation between the increase in the diffusional permeability of the blood-central nervous system barrier and other changes during the development of experimental allergic encephalomyelitis in the Lewis rat.
Daniel PM; Lam DK; Pratt OE
J Neurol Sci; 1983; 60(3):367-76. PubMed ID: 6415240
[TBL] [Abstract][Full Text] [Related]
17. Brain and spinal cord levels of histamine in Lewis rats with acute experimental autoimmune encephalomyelitis.
Orr EL; Stanley NC
J Neurochem; 1989 Jul; 53(1):111-8. PubMed ID: 2786054
[TBL] [Abstract][Full Text] [Related]
18. Blockade of Arginine Vasopressin receptors prevents blood-brain barrier breakdown in Experimental Autoimmune Encephalomyelitis.
Viñuela-Berni V; Gómez-González B; Quintanar-Stephano A
Sci Rep; 2020 Jan; 10(1):467. PubMed ID: 31949182
[TBL] [Abstract][Full Text] [Related]
19. The relationship between aquaporin-4 expression and blood-brain and spinal cord barrier permeability following experimental autoimmune encephalomyelitis in the rat.
Huang XN; Wang WZ; Fu J; Wang HB
Anat Rec (Hoboken); 2011 Jan; 294(1):46-54. PubMed ID: 21157915
[TBL] [Abstract][Full Text] [Related]
20. The distribution of immunoglobulins and albumin in the central nervous system in acute experimental allergic encephalomyelitis.
Juhler M; Laursen H; Barry DI
Acta Neurol Scand; 1986 Feb; 73(2):119-24. PubMed ID: 3518328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
